中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2012年
5期
49-51
,共3页
郭攀%王平%刘毓%王东伟%皮睿
郭攀%王平%劉毓%王東偉%皮睿
곽반%왕평%류육%왕동위%피예
急性心力衰竭%重组人脑利钠肽%治疗
急性心力衰竭%重組人腦利鈉肽%治療
급성심력쇠갈%중조인뇌리납태%치료
Acute heart failure%Recombinant human brain natriuretic peptide%Treatment
[目的]探讨重组人脑利钠肽(rhBNP)治疗急性心力衰竭的疗效和安全性.[方法]将48例急性心力衰竭患者随机分为两组:rhBNP组(n=24)以rhBNP静脉推注1.5μg/kg,再以0.0075~0.01 μg/( kg·min)持续泵入3d;对照组(n=22)泵入硝普钠,起始剂量为5μg/min,根据血压调速,每次增加5μg/min,直至达临床效应,持续用3d.记录两组患者治疗前后的全身状况、心脏超声学指标及临床疗效;记录两组患者的不良反应及不良心血管事件.[结果]治疗3d后,rhBNP组临床疗效、心率和尿量优于对照组(P<0.05);rhBNP组治疗后心脏指数、舒张功能指标较对照组改善(P<0.05).在药物的不良反应方面两组比较差异无统计学意义(P<0.05).[结论]rhBNP治疗急性心力衰竭的临床疗效显著,可明显改善心脏收缩、舒张功能,治疗安全可靠.
[目的]探討重組人腦利鈉肽(rhBNP)治療急性心力衰竭的療效和安全性.[方法]將48例急性心力衰竭患者隨機分為兩組:rhBNP組(n=24)以rhBNP靜脈推註1.5μg/kg,再以0.0075~0.01 μg/( kg·min)持續泵入3d;對照組(n=22)泵入硝普鈉,起始劑量為5μg/min,根據血壓調速,每次增加5μg/min,直至達臨床效應,持續用3d.記錄兩組患者治療前後的全身狀況、心髒超聲學指標及臨床療效;記錄兩組患者的不良反應及不良心血管事件.[結果]治療3d後,rhBNP組臨床療效、心率和尿量優于對照組(P<0.05);rhBNP組治療後心髒指數、舒張功能指標較對照組改善(P<0.05).在藥物的不良反應方麵兩組比較差異無統計學意義(P<0.05).[結論]rhBNP治療急性心力衰竭的臨床療效顯著,可明顯改善心髒收縮、舒張功能,治療安全可靠.
[목적]탐토중조인뇌리납태(rhBNP)치료급성심력쇠갈적료효화안전성.[방법]장48례급성심력쇠갈환자수궤분위량조:rhBNP조(n=24)이rhBNP정맥추주1.5μg/kg,재이0.0075~0.01 μg/( kg·min)지속빙입3d;대조조(n=22)빙입초보납,기시제량위5μg/min,근거혈압조속,매차증가5μg/min,직지체림상효응,지속용3d.기록량조환자치료전후적전신상황、심장초성학지표급림상료효;기록량조환자적불량반응급불양심혈관사건.[결과]치료3d후,rhBNP조림상료효、심솔화뇨량우우대조조(P<0.05);rhBNP조치료후심장지수、서장공능지표교대조조개선(P<0.05).재약물적불량반응방면량조비교차이무통계학의의(P<0.05).[결론]rhBNP치료급성심력쇠갈적림상료효현저,가명현개선심장수축、서장공능,치료안전가고.
[Objective]To investigate the efficacy and safety of recombinant hunan brain natriuretic peptide(rhBNP) in the treatment of acrte heart failure.[Methods]Forty-eight patients with acute heart failure were randomly divided into rhBNP group and control group.Patients in rhBNP group received rhBNP [1.5μg/kg intravenous infusion followed by 0.0075~0.01μg/(kg·min) for 3 days,n =24],and patients in control group received nitroprusside (starting at 5μg/min and increasing 5μg/min each time till clinical effective dose for 3 days,n =22).The clinical effectiveness,general physical condition,parameters of heart function examined by echocardiography were recorded before and after treatment in the two groups.The adverse drug reactions and adverse cardiovascular events were recorded.[Results]The clinical effect,heart rate and urine output were better in rhBNP group than those in control group after 3 days treatment(P<0.05).The indexes of left ventricular contraction and relaxation ftnctions in rhBNP group were higher than those in control group after treatment(P<0.05).There was no significant difference in the adverse durg reactions between the two groups (P<0.05).[Conclusions]Intravenous infusion of rhBNP is effective and safe for acute heart failure patients.It can obviously improve the heart systolic and diastolic fumctioNS.